12:00 AM
 | 
May 31, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

EpiCept NP-1: Completed Phase IIb enrollment

EpiCept completed enrollment of >400 patients in a 6-week, double-blind, placebo-controlled Phase IIb trial evaluating topical EpiCept NP-1.

EpiCept Corp....

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >